Is There any Association Between Celiac Disease and Helicobacter pylori?

Ahmet Uyanikoglu1, Huseyin Dursun2, Necati Yenice1

  • 1Department of Gastroenterology, Harran University, Sanliurfa, Turkey.

Insights

This study found no significant correlation between celiac disease (CD) and Helicobacter pylori (H. pylori) infection, as prevalence rates were similar in both groups. Further research is recommended to explore potential links.

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion.
  • Helicobacter pylori (H. pylori) is a common bacterial pathogen affecting the upper gastrointestinal tract.
  • The potential association between CD and H. pylori remains an area of investigation.

Purpose of the Study:

  • To investigate the correlation between celiac disease and Helicobacter pylori infection.
  • To compare the prevalence of H. pylori in patients diagnosed with CD versus a control group.

Main Methods:

  • Retrospective analysis of patients diagnosed with CD and tested for H. pylori.
  • Inclusion of a control group of patients undergoing gastroscopy and tested for H. pylori.
  • Comparison of H. pylori prevalence between the CD and control groups.

Main Results:

  • H. pylori prevalence was 48% in the CD group (15/31 patients).
  • H. pylori prevalence was 53.4% in the control group (316/592 patients).
  • The difference in H. pylori prevalence between the groups was not statistically significant (p > 0.5).

Conclusions:

  • No statistically significant correlation was found between celiac disease and H. pylori infection.
  • While H. pylori prevalence was slightly lower in celiac patients, the difference was not significant.
  • Further studies are warranted to fully elucidate any potential relationship between CD and H. pylori.
Abstract

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.3K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
901
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.4K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
650
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.4K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K